CPIX
Cumberland Pharmaceuticals Inc
6.90$
-3.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5.0% | 13.5% | 9.5% | 8.7% | 9.5% | 7.8% | 10.5% | 10.3% | 17.0% | 13.7% | 14.8% | 18.0% | 17.9% | 18.1% | 21.6% | 23.1% | 24.5% | 21.7% | 15.3% | 17.4% | 15.0% | |
| 95.0% | 86.5% | 90.5% | 91.3% | 90.5% | 92.2% | 89.5% | 89.7% | 83.0% | 86.3% | 85.2% | 82.0% | 82.1% | 81.9% | 78.4% | 76.9% | 75.5% | 78.3% | 84.7% | 82.6% | 85.0% | |
| 10.8% | 12.5% | 13.2% | 12.6% | 11.5% | 9.4% | 9.8% | 10.4% | 17.5% | 9.2% | 11.5% | 9.7% | 9.5% | 18.0% | 20.0% | 15.4% | 15.8% | 15.9% | 14.8% | 12.7% | 12.5% | |
| 24.2% | 16.8% | 14.7% | 14.7% | 17.6% | 17.4% | 18.0% | 18.6% | 29.6% | 22.8% | 22.7% | 25.9% | 24.4% | 25.5% | 29.0% | 27.2% | 27.2% | 24.2% | 26.9% | 29.4% | 26.8% | |
| 88.0% | 74.1% | 66.5% | 70.6% | 77.2% | 78.0% | 70.3% | 71.6% | 94.9% | 76.7% | 81.9% | 86.3% | 92.0% | 100.0% | 105.4% | 93.9% | 96.8% | 91.9% | 108.8% | 99.6% | 91.3% | |
| 7.0% | 12.5% | 24.0% | 20.8% | 13.3% | 14.2% | 19.3% | 18.1% | -11.9% | 9.6% | -3.3% | -4.3% | -9.9% | -18.1% | -27.0% | -17.0% | -21.3% | -13.6% | -24.2% | -17.0% | -6.3% | |
| 0.6% | 4.1% | 2.3% | 0.6% | 1.8% | 3.1% | 0.7% | 0.1% | 0.3% | 0.2% | 0.2% | 0.3% | 0.2% | 0.5% | 0.7% | 0.7% | 0.3% | 1.4% | 1.7% | 1.6% | 1.1% | |
| 7.2% | 9.6% | 23.0% | 20.8% | 11.7% | 11.5% | 19.0% | 18.5% | -11.5% | 10.1% | 3.7% | -4.0% | -9.4% | -17.2% | -27.0% | -17.5% | -15.5% | -13.3% | -15.9% | -17.1% | -6.3% | |
| -11.1% | -15.1% | 8.6% | 7.3% | 4.6% | 6.2% | 8.0% | 6.6% | -4.8% | 3.7% | 1.7% | -1.0% | 10.1% | 0.0% | -0.2% | 0.1% | 0.1% | 0.2% | 0.1% | -0.1% | 0.1% | |
| 18.3% | 24.7% | 14.4% | 13.6% | 7.1% | 5.4% | 11.1% | 12.0% | -6.6% | 6.6% | 2.2% | -2.9% | -19.4% | -17.1% | -10.3% | -8.9% | -9.7% | -13.3% | -15.9% | -17.1% | -6.4% | |
| 8.3% | 16.9% | 28.0% | 23.7% | 15.3% | 16.7% | 21.5% | 20.5% | -7.1% | 15.5% | 10.6% | 3.5% | -2.8% | -20.1% | -13.5% | -4.2% | -2.4% | 0.8% | 0.4% | 0.5% | 6.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.